Proteomic technology for biomarker profiling in cancer: an update.

Journal of Zhejiang University. Science. B
Moulay A Alaoui-Jamali, Ying-jie Xu

Abstract

The progress in the understanding of cancer progression and early detection has been slow and frustrating due to the complex multifactorial nature and heterogeneity of the cancer syndrome. To date, no effective treatment is available for advanced cancers, which remain a major cause of morbidity and mortality. Clearly, there is urgent need to unravel novel biomarkers for early detection. Most of the functional information of the cancer-associated genes resides in the proteome. The later is an exceptionally complex biological system involving several proteins that function through posttranslational modifications and dynamic intermolecular collisions with partners. These protein complexes can be regulated by signals emanating from cancer cells, their surrounding tissue microenvironment, and/or from the host. Some proteins are secreted and/or cleaved into the extracellular milieu and may represent valuable serum biomarkers for diagnosis purpose. It is estimated that the cancer proteome may include over 1.5 million proteins as a result of posttranslational processing and modifications. Such complexity clearly highlights the need for ultra-high resolution proteomic technology for robust quantitative protein measurements and data acqu...Continue Reading

References

May 3, 2001·Nature·J Ziauddin, D M Sabatini
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·J E StauntonT R Golub
Nov 20, 2001·Chemical Reviews·R Aebersold, D R Goodlett
Nov 28, 2001·Proteomics·V KnezevicD B Krizman
Feb 2, 2002·Nature·Laura J van 't VeerStephen H Friend
Feb 28, 2002·Lancet·Emanuel F PetricoinLance A Liotta
May 3, 2002·Analytical Chemistry·Maureen T KachmanDavid M Lubman
May 7, 2002·Nature Reviews. Cancer·David Sidransky
Jun 14, 2002·Seminars in Oncology·M Elizabeth H Hammond, Sheila E Taube
Jul 4, 2002·Molecular & Cellular Proteomics : MCP·Julio E CelisIrina Gromova
Sep 5, 2002·Nature Reviews. Drug Discovery·Emanuel F PetricoinLance A Liotta
Dec 19, 2002·Molecular & Cellular Proteomics : MCP·N Leigh Anderson, Norman G Anderson
Dec 20, 2002·The New England Journal of Medicine·Marc J van de VijverRené Bernards
Feb 1, 2003·Cancer Cell·Julio E Celis, Pavel Gromov
Mar 1, 2003·Nature Genetics·Allan BalmainBruce Ponder
Mar 14, 2003·Nature·Mike Tyers, Matthias Mann
Mar 14, 2003·Nature·Ruedi Aebersold, Matthias Mann
Mar 14, 2003·Nature·Eric PhizickyStanley Fields
Mar 14, 2003·Nature·Sam Hanash
Mar 14, 2003·Nature·Mark S Boguski, Martin W McIntosh
Apr 3, 2003·Nature Reviews. Cancer·Julia D WulfkuhleEmanuel F Petricoin
Apr 15, 2003·Nature Biotechnology·Christine C WuJohn R Yates
May 2, 2003·Nature Biotechnology·Owen OzierTrey Ideker
Aug 19, 2003·Proteomics·Pier Giorgio RighettiJoël S Rossier
Nov 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Satoshi NishizukaJohn N Weinstein
Jul 31, 2004·Urologic Oncology·Emanuel F PetricoinLance A Liotta
Aug 18, 2004·Nature Biotechnology·Blagoy BlagoevMatthias Mann
Jun 22, 2005·Expert Review of Proteomics·Kathryn S Lilley, David B Friedman
Jun 29, 2005·Proteomics·Sabine P SchrimpfPeter Sonderegger
Aug 25, 2005·Nature Methods·Nadim JessaniBenjamin F Cravatt
Aug 27, 2005·Proteomics·Sergei A MoshkovskiiAlexander I Archakov
Oct 8, 2005·Expert Review of Proteomics·Thomas P ConradsTimothy D Veenstra
Oct 12, 2005·Molecular & Cellular Proteomics : MCP·Claire RamusJérôme Garin
Oct 21, 2005·Proteomics·Katherine R KozakRobin Farias-Eisner
Oct 22, 2005·Nature Reviews. Cancer·Joseph A Ludwig, John N Weinstein
Oct 26, 2005·BMC Genomics·Ian P ShadforthConrad Bessant

❮ Previous
Next ❯

Citations

Jan 23, 2010·Journal of Biosciences·Mee Lee LooiYasmin Anum Mohd Yusof
Dec 8, 2010·Biomarkers in Medicine·Jeanne M RheaRoss J Molinaro
Jan 1, 2009·Human Genomics and Proteomics : HGP·Kondethimmanahalli Chandramouli, Pei-Yuan Qian
Nov 21, 2007·International Journal of Medical Sciences·Klaus BraunWaldemar Waldeck
May 1, 2008·Expert Opinion on Medical Diagnostics·Joel Lanoix, Eustache Paramithiotis
Dec 19, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Mi-Ryung Kim, Chan-Wha Kim
Jan 31, 2009·Veterinary and Comparative Oncology·B Matharoo-BallR Rees
Dec 17, 2014·Proteomics. Clinical Applications·Maja LudvigsenBent Honoré
Nov 7, 2008·Journal of Zhejiang University. Science. B·Hussain Montazery-KordyMohammad Hassan Moradi
Jan 7, 2014·Journal of Zhejiang University. Science. B·Juliana FelgueirasMargarida Fardilha
Aug 21, 2009·Journal of Proteome Research·Marta MongeMiguel Abal
Jul 3, 2021·Proteomes·Jagajjit Sahu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Related Papers

Clinica Chimica Acta; International Journal of Clinical Chemistry
Shu-Ling Liang, Daniel W Chan
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer
Mukesh Verma, Sudhir Srivastava
The International Journal of Biochemistry & Cell Biology
Eliezer Kopf, Dorit Zharhary
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Alice T ShawTyler Jacks
© 2022 Meta ULC. All rights reserved